======= ENAH =======
== Gene Information ==
* **Official Symbol**: ENAH
* **Official Name**: ENAH actin regulator
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55740|55740]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8N8S7|Q8N8S7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ENAH&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ENAH|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609061|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the enabled/ vasodilator-stimulated phosphoprotein. Members of this gene family are involved in actin-based motility. This protein is involved in regulating the assembly of actin filaments and modulates cell adhesion and motility. Alternate splice variants of this gene have been correlated with tumor invasiveness in certain tissues and these variants may serve as prognostic markers. A pseudogene of this gene is found on chromosome 3. [provided by RefSeq, Sep 2016].
* **UniProt Summary**: Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts synergistically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation (By similarity). {ECO:0000250, ECO:0000269|PubMed:11696321, ECO:0000269|PubMed:18158903}.
|WH1|
|VASP|
|VASP tetra|
|actin polymerization-dependent cell motility|
|profilin binding|
|WW domain binding|
|actin polymerization or depolymerization|
|filopodium|
|SH3 domain binding|
|lamellipodium|
|actin filament organization|
|axon guidance|
|neuron projection guidance|
|synapse|
|actin binding|
|cytoskeleton|
|axonogenesis|
|axon development|
|focal adhesion|
|cell morphogenesis involved in neuron differentiation|
|supramolecular fiber organization|
|neuron projection morphogenesis|
|plasma membrane bounded cell projection morphogenesis|
|cell projection morphogenesis|
|actin cytoskeleton organization|
|cell part morphogenesis|
|cell junction|
|chemotaxis|
|taxis|
|cell morphogenesis involved in differentiation|
|actin filament-based process|
|neuron projection development|
|cell morphogenesis|
|neuron development|
|cellular component morphogenesis|
|neuron differentiation|
|cell motility|
|localization of cell|
|cytoskeleton organization|
|plasma membrane bounded cell projection organization|
|cell projection organization|
|locomotion|
|generation of neurons|
|movement of cell or subcellular component|
|neurogenesis|
|cell development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp375|Lenalidomide 20μM R07 exp375]]|-1.81|
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|-1.79|
|[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|1.81|
|[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|1.83|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5571
* **Expression level (log2 read counts)**: 5.68
{{:chemogenomics:nalm6 dist.png?nolink |}}